Stimulant Laxative [EPC]

Stimulant Laxative [EPC] was reported 14386 times

Drugs of the Stimulant Laxative [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HYPOKINETIC DYSARTHRIA 23 0.7667
1 VAGINAL FLATULENCE 189 0.6238
2 APPENDICOLITH 208 0.5375
3 ANTACID THERAPY 67 0.5154
4 SLEEP DISORDER THERAPY 102 0.5152
5 TOTAL LUNG CAPACITY INCREASED 102 0.3750
6 ANALGESIC THERAPY 100 0.3115
7 DRUG THERAPY 96 0.2832
8 CONGENITAL HIATUS HERNIA 61 0.2675
9 MALIGNANT MELANOMA STAGE 0 51 0.2440
10 ANTICOAGULANT THERAPY 64 0.2254
11 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 102 0.1950
12 IVTH NERVE PARALYSIS 42 0.1772
13 VICTIM OF CHILD ABUSE 42 0.1673
14 BACTEROIDES INFECTION 41 0.1571
15 CEREBRAL HYPOPERFUSION 73 0.1567
16 EPIDURAL LIPOMATOSIS 53 0.1541
17 CHILD ABUSE 39 0.1506
18 CAPILLARITIS 37 0.1341
19 BINOCULAR EYE MOVEMENT DISORDER 35 0.1215
20 SEDATION COMPLICATION 305 0.1194
21 FEMALE GENITAL TRACT FISTULA 200 0.1170
22 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 108 0.1165
23 TOTAL LUNG CAPACITY ABNORMAL 43 0.1105
24 MULTIPLE DRUG THERAPY 79 0.1048
25 CEREBELLAR STROKE 35 0.0895
26 PULMONARY VASCULITIS 47 0.0874
27 RADICULOPATHY 202 0.0766
28 SPIROMETRY ABNORMAL 45 0.0753
29 MITE ALLERGY 48 0.0733
30 COLONIC PSEUDO-OBSTRUCTION 20 0.0717
31 CREATININE RENAL CLEARANCE DECREASED 285 0.0711
32 PROCTITIS 195 0.0695
33 CREATININE RENAL CLEARANCE INCREASED 52 0.0695
34 CHRONIC SINUSITIS 258 0.0687
35 MACULAR DEGENERATION 789 0.0660
36 HYPERPHOSPHATAEMIA 142 0.0660
37 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 48 0.0655
38 LEUKOPLAKIA 15 0.0612
39 BLOOD PHOSPHORUS INCREASED 158 0.0578
40 MYCOTIC ALLERGY 48 0.0561
41 TOTAL LUNG CAPACITY DECREASED 86 0.0538
42 HYPOMANIA 185 0.0503
43 JAUNDICE CHOLESTATIC 176 0.0498
44 DUST ALLERGY 48 0.0489
45 PNEUMOCOCCAL INFECTION 24 0.0405
46 PLEURITIC PAIN 96 0.0347
47 CONJUNCTIVITIS ALLERGIC 51 0.0344
48 NEURITIS 51 0.0330
49 INTESTINAL PSEUDO-OBSTRUCTION 29 0.0330
50 OROMANDIBULAR DYSTONIA 24 0.0329
51 LUNG OPACITY 86 0.0326
52 RESPIRATORY SYMPTOM 85 0.0299
53 DYSPRAXIA 16 0.0284
54 BLOOD CALCIUM DECREASED 303 0.0269
55 BRONCHIECTASIS 180 0.0267
56 IGA NEPHROPATHY 44 0.0265
57 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 27 0.0254
58 PLICATED TONGUE 12 0.0252
59 RHINITIS ALLERGIC 111 0.0249
60 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 50 0.0245
61 APPENDICITIS 221 0.0236
62 IRON DEFICIENCY 105 0.0233
63 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 118 0.0233
64 ORTHOSTATIC HYPOTENSION 402 0.0231
65 JUVENILE IDIOPATHIC ARTHRITIS 55 0.0225
66 BLOOD URIC ACID INCREASED 129 0.0223
67 NASAL POLYPS 107 0.0217
68 SARCOIDOSIS 103 0.0217
69 NEPHROGENIC ANAEMIA 99 0.0214
70 HYPOPHOSPHATAEMIA 153 0.0207
71 SCHIZOPHRENIA 251 0.0206
72 HYPORESPONSIVE TO STIMULI 23 0.0196
73 VENTRICULAR FIBRILLATION 214 0.0192
74 AORTIC STENOSIS 67 0.0192
75 MYASTHENIA GRAVIS 155 0.0192
76 VAGINAL DISCHARGE 191 0.0189
77 NORMOCHROMIC NORMOCYTIC ANAEMIA 56 0.0186
78 HYPERPARATHYROIDISM SECONDARY 45 0.0179
79 ORAL CANDIDIASIS 224 0.0170
80 REDUCED FACIAL EXPRESSION 17 0.0167
81 PARAESTHESIA ORAL 240 0.0166
82 RENAL FUNCTION TEST ABNORMAL 74 0.0159
83 CARDIOGENIC SHOCK 228 0.0159
84 FORCED EXPIRATORY VOLUME DECREASED 45 0.0159
85 HYPOGONADISM 15 0.0148
86 SLOW RESPONSE TO STIMULI 18 0.0139
87 SEDATION 360 0.0137
88 BLOOD CALCIUM INCREASED 119 0.0136
89 CARDIAC MURMUR 115 0.0133
90 EFFUSION 18 0.0132
91 RALES 76 0.0131
92 ASPIRATION 140 0.0128
93 END STAGE RENAL DISEASE 227 0.0124
94 BENIGN PROSTATIC HYPERPLASIA 62 0.0120
95 TROPONIN INCREASED 91 0.0119
96 BREATH SOUNDS ABNORMAL 56 0.0113
97 RESPIRATORY DEPRESSION 136 0.0111
98 REBOUND ACID HYPERSECRETION 33 0.0109
99 OBSTRUCTIVE AIRWAYS DISORDER 118 0.0106
100 PELVIC ABSCESS 12 0.0104
101 ON AND OFF PHENOMENON 57 0.0103
102 PULMONARY ALVEOLAR HAEMORRHAGE 55 0.0098
103 COGNITIVE DISORDER 457 0.0098
104 ARTERIOSCLEROSIS CORONARY ARTERY 64 0.0097
105 MUTISM 14 0.0096
106 TONGUE DRY 13 0.0096
107 ASCITES 278 0.0094
108 MULTIPLE ORGAN DYSFUNCTION SYNDROME 267 0.0094
109 NEUROLOGICAL SYMPTOM 53 0.0093
110 ORAL MUCOSAL EXFOLIATION 14 0.0092
111 NEURALGIA 224 0.0092
112 NEUROGENIC BLADDER 19 0.0090
113 SEBORRHOEIC KERATOSIS 13 0.0089
114 CHOLELITHIASIS 291 0.0089
115 EXCESSIVE EYE BLINKING 13 0.0088
116 FULL BLOOD COUNT ABNORMAL 93 0.0088
117 HYPERLIPIDAEMIA 104 0.0087
118 DEPRESSED LEVEL OF CONSCIOUSNESS 343 0.0087
119 MICTURITION URGENCY 99 0.0087
120 BLOOD TEST ABNORMAL 120 0.0085
121 HEPATOTOXICITY 186 0.0083
122 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 143 0.0083
123 PRODUCT MONITORING ERROR 12 0.0083
124 BACTERIAL INFECTION 155 0.0083
125 FREQUENT BOWEL MOVEMENTS 222 0.0082
126 CLOSTRIDIUM TEST POSITIVE 18 0.0082
127 ANTICHOLINERGIC SYNDROME 13 0.0082
128 PROCEDURAL PAIN 226 0.0081
129 ARTERIOSCLEROSIS 76 0.0081
130 STOMA SITE ERYTHEMA 15 0.0080
131 LUNG NEOPLASM 34 0.0080
132 SPUTUM DISCOLOURED 75 0.0079
133 BLOOD BILIRUBIN INCREASED 213 0.0079
134 SUBILEUS 16 0.0077
135 CONSTIPATION 1623 0.0074
136 GLOSSITIS 26 0.0073
137 HYPONATRAEMIA 409 0.0073
138 MONOCYTE COUNT INCREASED 26 0.0072
139 LARGE INTESTINAL ULCER 19 0.0070
140 DECUBITUS ULCER 57 0.0070
141 PULMONARY FIBROSIS 134 0.0070
142 ULCER 111 0.0070
143 PSYCHOTIC DISORDER 205 0.0069
144 ATELECTASIS 67 0.0069
145 HYPOXIA 242 0.0069
146 FAILURE TO THRIVE 34 0.0065
147 COLITIS 248 0.0065
148 PULMONARY MASS 96 0.0064
149 METABOLIC ENCEPHALOPATHY 19 0.0063
150 RECTAL HAEMORRHAGE 269 0.0063
151 RENAL FAILURE CHRONIC 48 0.0062
152 GOUT 112 0.0062
153 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 323 0.0062
154 STOMA SITE DISCHARGE 16 0.0058
155 BALANCE DISORDER 499 0.0058
156 LISTLESS 19 0.0058
157 UROSEPSIS 53 0.0057
158 HEPARIN-INDUCED THROMBOCYTOPENIA 28 0.0057
159 HYPERCHOLESTEROLAEMIA 54 0.0056
160 WOUND COMPLICATION 19 0.0055
161 HOSTILITY 14 0.0055
162 FUNCTIONAL GASTROINTESTINAL DISORDER 19 0.0055
163 TONGUE DISCOLOURATION 24 0.0055
164 CANCER PAIN 14 0.0055
165 FAECALOMA 30 0.0055
166 MOBILITY DECREASED 387 0.0054
167 NON-CARDIAC CHEST PAIN 17 0.0054
168 HAEMOPTYSIS 149 0.0053
169 TRANSAMINASES INCREASED 117 0.0053
170 GASTROINTESTINAL MOTILITY DISORDER 28 0.0052
171 COLITIS ISCHAEMIC 35 0.0052
172 ILEUS PARALYTIC 23 0.0051
173 AZOTAEMIA 20 0.0050
174 LIVER FUNCTION TEST INCREASED 107 0.0050
175 BLADDER DISORDER 49 0.0049
176 DYSCHEZIA 15 0.0049
177 RED CELL DISTRIBUTION WIDTH INCREASED 20 0.0048
178 HAEMATOCHEZIA 265 0.0048
179 CATHETER SITE HAEMORRHAGE 12 0.0048
180 SMALL INTESTINAL OBSTRUCTION 59 0.0048
181 VASCULITIS 55 0.0047
182 FRUSTRATION TOLERANCE DECREASED 38 0.0047
183 TENDERNESS 49 0.0047
184 COLITIS ULCERATIVE 210 0.0047
185 NOCTURIA 57 0.0047
186 AORTIC ARTERIOSCLEROSIS 12 0.0047
187 PRODUCT PRESCRIBING ERROR 111 0.0047
188 CHRONIC KIDNEY DISEASE 349 0.0046
189 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 326 0.0046
190 OBESITY 73 0.0046
191 BLOOD ALBUMIN DECREASED 36 0.0045
192 SEPSIS 499 0.0045
193 PNEUMONIA ASPIRATION 111 0.0044
194 CLUMSINESS 12 0.0044
195 IMMOBILE 19 0.0043
196 SPINAL OSTEOARTHRITIS 38 0.0043
197 FREEZING PHENOMENON 16 0.0043
198 NEUTROPHIL COUNT INCREASED 44 0.0043
199 LUNG CONSOLIDATION 12 0.0043
200 GENERAL PHYSICAL HEALTH DETERIORATION 496 0.0043
201 RENAL TUBULAR NECROSIS 42 0.0043
202 ENDOTRACHEAL INTUBATION 12 0.0043
203 TUBULOINTERSTITIAL NEPHRITIS 80 0.0043
204 PLEURAL EFFUSION 259 0.0043
205 MENTAL STATUS CHANGES 118 0.0042
206 INFUSION RELATED REACTION 279 0.0042
207 PROSTATE CANCER METASTATIC 14 0.0042
208 WHEEZING 248 0.0042
209 BONE LESION 15 0.0042
210 ACUTE RESPIRATORY FAILURE 80 0.0042
211 RESPIRATORY RATE DECREASED 13 0.0041
212 SPINAL STENOSIS 17 0.0041
213 LUMBAR SPINAL STENOSIS 12 0.0041
214 LOCALISED OEDEMA 19 0.0041
215 ABDOMINAL DISTENSION 427 0.0041
216 HYPERNATRAEMIA 20 0.0040
217 FOREIGN BODY 16 0.0040
218 NODULE 52 0.0040
219 PROTEIN TOTAL DECREASED 15 0.0040
220 ECONOMIC PROBLEM 60 0.0040
221 HYPERURICAEMIA 16 0.0039
222 HOSPICE CARE 38 0.0038
223 ANAEMIA 733 0.0038
224 MUSCLE SPASTICITY 47 0.0038
225 IRON DEFICIENCY ANAEMIA 35 0.0038
226 BLOOD CREATININE INCREASED 247 0.0038
227 HYPOVOLAEMIA 22 0.0038
228 URINARY RETENTION 125 0.0037
229 PETIT MAL EPILEPSY 19 0.0037
230 FEELING COLD 103 0.0037
231 POSTURE ABNORMAL 12 0.0037
232 NECROTISING FASCIITIS 13 0.0037
233 DIVERTICULUM INTESTINAL 16 0.0037
234 LEUKOCYTOSIS 66 0.0036
235 HYPOKALAEMIA 168 0.0036
236 HYPOTENSION 725 0.0036
237 JOINT INJURY 77 0.0036
238 UNRESPONSIVE TO STIMULI 93 0.0036
239 FAECES HARD 14 0.0036
240 ANXIETY DISORDER 12 0.0036
241 CORONARY ARTERY DISEASE 108 0.0036
242 DYSARTHRIA 134 0.0036
243 ABDOMINAL PAIN 821 0.0035
244 ABSCESS LIMB 15 0.0035
245 GASTROOESOPHAGEAL REFLUX DISEASE 282 0.0035
246 PELVIC FRACTURE 27 0.0035
247 STAPHYLOCOCCAL BACTERAEMIA 15 0.0034
248 BLOOD CHOLESTEROL INCREASED 160 0.0034
249 PROCTALGIA 22 0.0034
250 GINGIVAL SWELLING 15 0.0034
251 OEDEMA PERIPHERAL 412 0.0034
252 PULSELESS ELECTRICAL ACTIVITY 14 0.0033
253 HYPOVOLAEMIC SHOCK 16 0.0033
254 SPINAL CORD COMPRESSION 13 0.0033
255 UPPER RESPIRATORY TRACT INFECTION 153 0.0033
256 PRESYNCOPE 80 0.0033
257 THERAPEUTIC PRODUCT EFFECT DELAYED 15 0.0033
258 PULMONARY EMBOLISM 308 0.0032
259 DEMENTIA 90 0.0032
260 MALNUTRITION 36 0.0032
261 SLEEP DISORDER 227 0.0032
262 LOWER RESPIRATORY TRACT INFECTION 146 0.0032
263 RESPIRATION ABNORMAL 22 0.0032
264 HAEMORRHAGIC ANAEMIA 14 0.0032
265 ODYNOPHAGIA 19 0.0032
266 ENCEPHALOPATHY 78 0.0032
267 CATHETER SITE INFECTION 12 0.0032
268 DELIRIUM 109 0.0031
269 DYSPEPSIA 309 0.0031
270 BOWEL MOVEMENT IRREGULARITY 24 0.0031
271 INCONTINENCE 33 0.0031
272 GINGIVAL DISORDER 12 0.0031
273 ANAL INCONTINENCE 28 0.0031
274 PERIPHERAL VASCULAR DISORDER 16 0.0031
275 ACUTE KIDNEY INJURY 471 0.0031
276 ESCHERICHIA URINARY TRACT INFECTION 13 0.0031
277 THROMBOSIS 246 0.0031
278 TEARFULNESS 13 0.0030
279 CLOSTRIDIUM DIFFICILE COLITIS 32 0.0030
280 HYPOPHAGIA 77 0.0030
281 CEREBRAL ATROPHY 12 0.0030
282 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 51 0.0030
283 FLUID INTAKE REDUCED 15 0.0030
284 GRANULOCYTOPENIA 17 0.0030
285 HEPATIC ENZYME INCREASED 203 0.0030
286 LUNG INFILTRATION 26 0.0029
287 PNEUMONIA BACTERIAL 27 0.0029
288 PERIPHERAL ISCHAEMIA 12 0.0029
289 HAEMATOCRIT DECREASED 58 0.0029
290 CACHEXIA 15 0.0029
291 DRUG DIVERSION 18 0.0029
292 SCOLIOSIS 18 0.0029
293 TRISMUS 15 0.0029
294 POLYP 19 0.0029
295 INTENTIONAL PRODUCT MISUSE 254 0.0029
296 TRICUSPID VALVE INCOMPETENCE 23 0.0029
297 ATRIAL FLUTTER 23 0.0029
298 INTERNATIONAL NORMALISED RATIO INCREASED 82 0.0029
299 WEIGHT FLUCTUATION 30 0.0029
300 UPPER GASTROINTESTINAL HAEMORRHAGE 48 0.0029
301 MUSCLE RIGIDITY 34 0.0028
302 OSTEOPENIA 43 0.0028
303 HYPERVOLAEMIA 14 0.0028
304 HYPOALBUMINAEMIA 22 0.0028
305 HYPOKINESIA 41 0.0028
306 HYPOTHYROIDISM 90 0.0028
307 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
308 RENAL FAILURE 372 0.0028
309 FEBRILE NEUTROPENIA 185 0.0028
310 IMPAIRED GASTRIC EMPTYING 38 0.0028
311 HEPATIC LESION 12 0.0028
312 GINGIVAL PAIN 22 0.0028
313 QUALITY OF LIFE DECREASED 37 0.0028
314 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 15 0.0028
315 GROIN PAIN 24 0.0027
316 ORAL DISORDER 20 0.0027
317 HAEMORRHOIDS 53 0.0027
318 BRADYKINESIA 16 0.0027
319 TOXICITY TO VARIOUS AGENTS 456 0.0027
320 ENTEROCOCCAL INFECTION 13 0.0027
321 DRY MOUTH 218 0.0027
322 APLASTIC ANAEMIA 14 0.0027
323 FALL 891 0.0027
324 DIABETES MELLITUS 204 0.0027
325 RENAL FAILURE ACUTE 113 0.0027
326 PNEUMONIA 862 0.0027
327 ILEUS 33 0.0027
328 URINARY INCONTINENCE 78 0.0026
329 METASTASES TO BONE 43 0.0026
330 DRUG ABUSE 218 0.0026
331 TUMOUR LYSIS SYNDROME 23 0.0026
332 COMPRESSION FRACTURE 14 0.0026
333 INTERVERTEBRAL DISC DEGENERATION 24 0.0026
334 MOUTH HAEMORRHAGE 19 0.0026
335 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 16 0.0026
336 TACHYPNOEA 35 0.0026
337 NEPHROPATHY 24 0.0026
338 HICCUPS 21 0.0026
339 LUNG NEOPLASM MALIGNANT 105 0.0026
340 BLOOD PROLACTIN INCREASED 12 0.0025
341 SPINAL COMPRESSION FRACTURE 21 0.0025
342 HYDRONEPHROSIS 19 0.0025
343 GENERAL SYMPTOM 19 0.0025
344 ENDOCARDITIS 13 0.0025
345 DIVERTICULUM 18 0.0025
346 TRANSIENT ISCHAEMIC ATTACK 85 0.0025
347 HYPOMAGNESAEMIA 35 0.0025
348 PROTHROMBIN TIME PROLONGED 15 0.0025
349 PRODUCTIVE COUGH 119 0.0025
350 RESPIRATORY FAILURE 181 0.0025
351 ECCHYMOSIS 17 0.0025
352 MITRAL VALVE INCOMPETENCE 28 0.0025
353 ANHEDONIA 65 0.0025
354 GASTRITIS 65 0.0025
355 BLOOD LACTIC ACID INCREASED 13 0.0025
356 RENAL INJURY 73 0.0025
357 URINARY TRACT INFECTION 419 0.0025
358 BLOOD ALKALINE PHOSPHATASE INCREASED 61 0.0025
359 FLANK PAIN 23 0.0025
360 LARGE INTESTINE PERFORATION 17 0.0024
361 LUNG DISORDER 119 0.0024
362 DIABETIC NEUROPATHY 12 0.0024
363 CYTOKINE RELEASE SYNDROME 48 0.0024
364 SKIN LACERATION 26 0.0024
365 BLOOD SODIUM DECREASED 45 0.0024
366 KLEBSIELLA INFECTION 12 0.0024
367 HAEMATEMESIS 60 0.0024
368 PATHOLOGICAL FRACTURE 12 0.0024
369 SENSORY LOSS 19 0.0024
370 GLOMERULAR FILTRATION RATE DECREASED 29 0.0024
371 SWELLING 219 0.0023
372 ASPARTATE AMINOTRANSFERASE INCREASED 124 0.0023
373 SEPTIC SHOCK 101 0.0023
374 MYOPATHY 20 0.0023
375 PYREXIA 800 0.0023
376 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 111 0.0023
377 SPEECH DISORDER 121 0.0023
378 VOMITING 1083 0.0023
379 BLOOD PRESSURE DIASTOLIC DECREASED 17 0.0023
380 RIB FRACTURE 47 0.0023
381 INTESTINAL OBSTRUCTION 86 0.0023
382 CARDIOMEGALY 28 0.0023
383 BLOOD LACTATE DEHYDROGENASE INCREASED 36 0.0023
384 BLOOD UREA INCREASED 38 0.0023
385 CONCOMITANT DISEASE AGGRAVATED 14 0.0023
386 RENAL CYST 18 0.0023
387 LYMPHOCYTE COUNT DECREASED 40 0.0023
388 CHOLANGITIS 14 0.0023
389 RESPIRATORY RATE INCREASED 20 0.0023
390 CARDIOVASCULAR DISORDER 57 0.0022
391 ELECTROLYTE IMBALANCE 26 0.0022
392 SUBDURAL HAEMATOMA 32 0.0022
393 INTESTINAL PERFORATION 25 0.0022
394 CELLULITIS 111 0.0022
395 HYDROCEPHALUS 12 0.0022
396 DIPLOPIA 57 0.0022
397 BACTERAEMIA 26 0.0022
398 AFFECT LABILITY 21 0.0022
399 INTESTINAL ISCHAEMIA 12 0.0022
400 URINE OUTPUT DECREASED 19 0.0022
401 TORSADE DE POINTES 17 0.0022
402 DEHYDRATION 289 0.0022
403 HEMIPLEGIA 18 0.0022
404 HAEMATURIA 74 0.0022
405 MUSCULOSKELETAL STIFFNESS 189 0.0022
406 HEAD INJURY 68 0.0021
407 PNEUMOTHORAX 34 0.0021
408 DRUG INTERACTION 340 0.0021
409 POOR QUALITY SLEEP 46 0.0021
410 DEVICE OCCLUSION 30 0.0021
411 CONDITION AGGRAVATED 646 0.0021
412 COVID-19 PNEUMONIA 25 0.0021
413 NEUTROPENIC SEPSIS 15 0.0021
414 OXYGEN SATURATION DECREASED 118 0.0021
415 TERMINAL STATE 14 0.0021
416 DYSPHONIA 122 0.0021
417 HERPES VIRUS INFECTION 12 0.0021
418 PRE-EXISTING CONDITION IMPROVED 13 0.0021
419 HYPERKALAEMIA 73 0.0021
420 ABNORMAL FAECES 17 0.0021
421 SOMNOLENCE 417 0.0021
422 CONCUSSION 16 0.0021
423 TACHYCARDIA 182 0.0020
424 RESPIRATORY DISTRESS 56 0.0020
425 HYPERCALCAEMIA 25 0.0020
426 HIP FRACTURE 65 0.0020
427 DYSKINESIA 82 0.0020
428 PULMONARY OEDEMA 90 0.0020
429 CARDIO-RESPIRATORY ARREST 84 0.0020
430 DRUG INTOLERANCE 194 0.0020
431 RIGHT VENTRICULAR FAILURE 14 0.0020
432 SENSORY DISTURBANCE 32 0.0020
433 STEVENS-JOHNSON SYNDROME 44 0.0020
434 BEDRIDDEN 26 0.0020
435 ASTHMA 222 0.0020
436 BLOOD POTASSIUM DECREASED 59 0.0020
437 WEIGHT DECREASED 543 0.0019
438 ESCHERICHIA INFECTION 16 0.0019
439 ALTERED STATE OF CONSCIOUSNESS 42 0.0019
440 MYOCLONUS 23 0.0019
441 POSTOPERATIVE WOUND INFECTION 13 0.0019
442 HAEMOGLOBIN DECREASED 197 0.0019
443 PAIN 1177 0.0019
444 MAJOR DEPRESSION 14 0.0019
445 CYSTITIS 61 0.0019
446 LETHARGY 110 0.0019
447 TRANSFUSION 20 0.0019
448 BRADYCARDIA 101 0.0019
449 TREMOR 316 0.0019
450 SPINAL DISORDER 18 0.0019
451 LOWER GASTROINTESTINAL HAEMORRHAGE 14 0.0019
452 JOINT EFFUSION 13 0.0019
453 LARGE INTESTINE POLYP 13 0.0019
454 NAUSEA 1483 0.0019
455 MUSCULOSKELETAL CHEST PAIN 29 0.0019
456 HAEMORRHAGE INTRACRANIAL 28 0.0019
457 AUTOIMMUNE HEPATITIS 13 0.0019
458 MIOSIS 15 0.0019
459 TOOTH ABSCESS 19 0.0019
460 BONE DISORDER 34 0.0019
461 SUBARACHNOID HAEMORRHAGE 19 0.0019
462 APHONIA 26 0.0019
463 SWOLLEN TONGUE 58 0.0019
464 HIATUS HERNIA 24 0.0019
465 HEPATITIS ACUTE 12 0.0018
466 TOXIC EPIDERMAL NECROLYSIS 28 0.0018
467 CARDIAC ARREST 152 0.0018
468 DIALYSIS 26 0.0018
469 LIPASE INCREASED 14 0.0018
470 PLASMA CELL MYELOMA 71 0.0018
471 RED BLOOD CELL COUNT DECREASED 52 0.0018
472 LACERATION 17 0.0018
473 GASTROINTESTINAL HAEMORRHAGE 151 0.0018
474 CARDIAC FAILURE ACUTE 12 0.0018
475 EOSINOPHIL COUNT INCREASED 15 0.0018
476 BRAIN INJURY 18 0.0018
477 CONFUSIONAL STATE 290 0.0018
478 ASTHENIA 674 0.0018
479 FACIAL PAIN 16 0.0018
480 GASTRIC ULCER 34 0.0018
481 ORAL PAIN 40 0.0018
482 INFUSION SITE ERYTHEMA 15 0.0018
483 DEEP VEIN THROMBOSIS 115 0.0018
484 OSTEOARTHRITIS 75 0.0018
485 ACUTE MYOCARDIAL INFARCTION 52 0.0018
486 GAMMA-GLUTAMYLTRANSFERASE INCREASED 39 0.0018
487 DYSPHAGIA 167 0.0018
488 MUCOSAL INFLAMMATION 46 0.0018
489 HALLUCINATION, VISUAL 37 0.0018
490 PSEUDOMONAS INFECTION 15 0.0017
491 SKIN ULCER 45 0.0017
492 WOUND INFECTION 19 0.0017
493 LIMB INJURY 47 0.0017
494 PETECHIAE 18 0.0017
495 LIVER FUNCTION TEST ABNORMAL 50 0.0017
496 MASS 24 0.0017
497 HEMIPARESIS 29 0.0017
498 METASTASES TO LIVER 30 0.0017
499 ACIDOSIS 13 0.0017
500 SALIVARY HYPERSECRETION 17 0.0017
501 HALLUCINATION 128 0.0017
502 ATRIAL FIBRILLATION 165 0.0017
503 WHITE BLOOD CELL COUNT INCREASED 65 0.0017
504 FLATULENCE 96 0.0017
505 HYPOCALCAEMIA 32 0.0017
506 DEVICE RELATED INFECTION 26 0.0017
507 SEIZURE 195 0.0017
508 EMBOLISM 14 0.0017
509 PULMONARY HYPERTENSION 35 0.0017
510 RHABDOMYOLYSIS 70 0.0017
511 OSTEOPOROSIS 69 0.0017
512 PARALYSIS 24 0.0017
513 SUPRAVENTRICULAR TACHYCARDIA 16 0.0017
514 APNOEA 13 0.0017
515 SEROTONIN SYNDROME 32 0.0017
516 DISORIENTATION 66 0.0017
517 FAECES DISCOLOURED 36 0.0017
518 MYOCARDITIS 19 0.0017
519 OSTEOMYELITIS 30 0.0017
520 CARDIAC FAILURE CONGESTIVE 133 0.0017
521 EATING DISORDER 35 0.0016
522 INCREASED TENDENCY TO BRUISE 15 0.0016
523 RHINITIS 13 0.0016
524 JOINT DISLOCATION 17 0.0016
525 STAPHYLOCOCCAL INFECTION 53 0.0016
526 HYPERTENSION 340 0.0016
527 OEDEMA 87 0.0016
528 SKIN LESION 44 0.0016
529 PRODUCT USE IN UNAPPROVED INDICATION 396 0.0016
530 EAR PAIN 31 0.0016
531 PULMONARY CONGESTION 21 0.0016
532 IRRITABLE BOWEL SYNDROME 34 0.0016
533 CIRCULATORY COLLAPSE 27 0.0016
534 DYSPNOEA 896 0.0016
535 COORDINATION ABNORMAL 22 0.0016
536 APATHY 23 0.0016
537 CLOSTRIDIUM DIFFICILE INFECTION 34 0.0016
538 PANCREATITIS ACUTE 35 0.0016
539 ELECTROCARDIOGRAM QT PROLONGED 56 0.0016
540 LYMPHADENOPATHY 55 0.0016
541 SINUS BRADYCARDIA 15 0.0016
542 GASTROENTERITIS VIRAL 28 0.0015
543 METASTASES TO CENTRAL NERVOUS SYSTEM 20 0.0015
544 TEMPERATURE INTOLERANCE 16 0.0015
545 SINUS TACHYCARDIA 22 0.0015
546 HAEMODIALYSIS 13 0.0015
547 MELAENA 34 0.0015
548 LUNG INFECTION 24 0.0015
549 VITAMIN D DEFICIENCY 15 0.0015
550 RESPIRATORY TRACT INFECTION 40 0.0015
551 LIVER DISORDER 68 0.0015
552 EXOSTOSIS 14 0.0015
553 GASTROINTESTINAL INFLAMMATION 12 0.0015
554 MUSCULAR WEAKNESS 174 0.0015
555 INADEQUATE ANALGESIA 13 0.0015
556 FLUID OVERLOAD 22 0.0015
557 ANURIA 13 0.0015
558 PERSONALITY CHANGE 14 0.0015
559 DECREASED APPETITE 350 0.0015
560 PNEUMONITIS 41 0.0015
561 PANCYTOPENIA 84 0.0015
562 OBSESSIVE-COMPULSIVE DISORDER 12 0.0015
563 DYSURIA 55 0.0015
564 TOOTHACHE 27 0.0015
565 FEMUR FRACTURE 46 0.0015
566 EJECTION FRACTION DECREASED 23 0.0015
567 FOOT FRACTURE 28 0.0015
568 ABDOMINAL PAIN UPPER 304 0.0015
569 THROMBOCYTOPENIA 165 0.0015
570 MOUTH ULCERATION 31 0.0015
571 PERICARDIAL EFFUSION 34 0.0015
572 STOMATITIS 89 0.0015
573 ERYTHEMA 301 0.0015
574 INTERVERTEBRAL DISC PROTRUSION 32 0.0015
575 HEART RATE IRREGULAR 33 0.0015
576 GASTROINTESTINAL PAIN 16 0.0015
577 TARDIVE DYSKINESIA 41 0.0015
578 TOOTH FRACTURE 16 0.0014
579 COAGULOPATHY 24 0.0014
580 GASTROENTERITIS 21 0.0014
581 DYSPNOEA EXERTIONAL 54 0.0014
582 PHARYNGEAL SWELLING 14 0.0014
583 HYPERGLYCAEMIA 52 0.0014
584 CHOLECYSTITIS 17 0.0014
585 BRAIN OEDEMA 18 0.0014
586 COLD SWEAT 25 0.0014
587 SUDDEN DEATH 15 0.0014
588 DELUSION 22 0.0014
589 FACIAL PARALYSIS 12 0.0014
590 DYSSTASIA 41 0.0014
591 HYPOGLYCAEMIA 68 0.0014
592 METASTASES TO LUNG 16 0.0014
593 PERIPHERAL COLDNESS 19 0.0014
594 LIP SWELLING 46 0.0014
595 PLATELET COUNT INCREASED 18 0.0014
596 FEEDING DISORDER 28 0.0014
597 ABSCESS 22 0.0014
598 FRACTURE 26 0.0014
599 BLOOD URINE PRESENT 26 0.0014
600 ALANINE AMINOTRANSFERASE INCREASED 84 0.0014
601 OFF LABEL USE 1196 0.0014
602 TOOTH INFECTION 18 0.0014
603 ABNORMAL BEHAVIOUR 54 0.0014
604 MENTAL IMPAIRMENT 33 0.0014
605 HEPATIC FAILURE 41 0.0014
606 SYNCOPE 136 0.0014
607 APHASIA 41 0.0014
608 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
609 PERITONITIS 28 0.0014
610 HYPERTENSIVE CRISIS 15 0.0013
611 ACUTE MYELOID LEUKAEMIA 21 0.0013
612 C-REACTIVE PROTEIN INCREASED 49 0.0013
613 HEPATIC STEATOSIS 25 0.0013
614 DIZZINESS POSTURAL 13 0.0013
615 PARANOIA 23 0.0013
616 BLOOD PRESSURE SYSTOLIC INCREASED 26 0.0013
617 CHOKING 26 0.0013
618 LIP DRY 12 0.0013
619 NEUROPATHY PERIPHERAL 125 0.0013
620 PLATELET COUNT DECREASED 140 0.0013
621 GAIT DISTURBANCE 251 0.0013
622 SLEEP APNOEA SYNDROME 25 0.0013
623 BACK PAIN 303 0.0013
624 NIGHT SWEATS 42 0.0013
625 POST PROCEDURAL COMPLICATION 25 0.0013
626 LOWER LIMB FRACTURE 25 0.0013
627 NEUTROPHIL COUNT DECREASED 53 0.0013
628 MALAISE 569 0.0013
629 HYPERHIDROSIS 167 0.0013
630 HUNGER 18 0.0013
631 GALLBLADDER DISORDER 23 0.0013
632 CHILLS 151 0.0013
633 CARDIOMYOPATHY 19 0.0013
634 RESTLESSNESS 47 0.0013
635 BLISTER 72 0.0013
636 SKIN HAEMORRHAGE 19 0.0013
637 OESOPHAGITIS 14 0.0013
638 SPLENOMEGALY 15 0.0013
639 SPINAL PAIN 15 0.0013
640 CYANOSIS 20 0.0013
641 CARDIAC FAILURE 102 0.0013
642 JOINT RANGE OF MOTION DECREASED 17 0.0013
643 RESTLESS LEGS SYNDROME 23 0.0013
644 CHEST PAIN 234 0.0013
645 EOSINOPHILIA 22 0.0013
646 VENTRICULAR EXTRASYSTOLES 13 0.0013
647 METABOLIC ACIDOSIS 40 0.0012
648 SKIN INFECTION 14 0.0012
649 TYPE 2 DIABETES MELLITUS 42 0.0012
650 POLLAKIURIA 52 0.0012
651 CHROMATURIA 28 0.0012
652 STATUS EPILEPTICUS 14 0.0012
653 GASTROINTESTINAL DISORDER 111 0.0012
654 BURSITIS 15 0.0012
655 ISCHAEMIC STROKE 22 0.0012
656 BLOOD POTASSIUM INCREASED 20 0.0012
657 AMNESIA 80 0.0012
658 NEPHROLITHIASIS 56 0.0012
659 BODY TEMPERATURE DECREASED 12 0.0012
660 BONE DENSITY DECREASED 38 0.0012
661 OSTEONECROSIS OF JAW 30 0.0012
662 GENERALISED OEDEMA 15 0.0012
663 BREAST CANCER METASTATIC 13 0.0012
664 AGEUSIA 30 0.0012
665 SEASONAL ALLERGY 17 0.0012
666 BONE LOSS 18 0.0012
667 SEXUAL DYSFUNCTION 14 0.0012
668 EMPHYSEMA 12 0.0012
669 ANGINA PECTORIS 34 0.0012
670 NEUTROPENIA 161 0.0012
671 MALIGNANT NEOPLASM PROGRESSION 121 0.0012
672 MOTOR DYSFUNCTION 12 0.0012
673 BODY TEMPERATURE INCREASED 24 0.0012
674 DENTAL CARIES 13 0.0012
675 BLOOD PRESSURE DECREASED 78 0.0012
676 CONTUSION 113 0.0012
677 LACTIC ACIDOSIS 38 0.0012
678 AGITATION 86 0.0012
679 SCAR 20 0.0012
680 HYPERBILIRUBINAEMIA 12 0.0012
681 MULTI-ORGAN FAILURE 20 0.0012
682 HEADACHE 721 0.0011
683 VERTIGO 70 0.0011
684 NO THERAPEUTIC RESPONSE 14 0.0011
685 DRUG LEVEL INCREASED 19 0.0011
686 CEREBRAL HAEMORRHAGE 41 0.0011
687 CYTOPENIA 14 0.0011
688 MYOCARDIAL ISCHAEMIA 13 0.0011
689 IMMUNODEFICIENCY 17 0.0011
690 FLUID RETENTION 58 0.0011
691 HEART RATE DECREASED 40 0.0011
692 EPISTAXIS 85 0.0011
693 DIABETES MELLITUS INADEQUATE CONTROL 20 0.0011
694 MUSCLE TWITCHING 26 0.0011
695 ANXIETY 321 0.0011
696 WHITE BLOOD CELL COUNT DECREASED 122 0.0011
697 TOOTH EXTRACTION 14 0.0011
698 RESPIRATORY ARREST 31 0.0011
699 POISONING 14 0.0011
700 COUGH 312 0.0011
701 BLOOD CREATINE PHOSPHOKINASE INCREASED 32 0.0011
702 COVID-19 195 0.0011
703 ACTIVITIES OF DAILY LIVING IMPAIRED 22 0.0011
704 TOOTH LOSS 23 0.0011
705 NECK PAIN 62 0.0011
706 LOSS OF CONSCIOUSNESS 142 0.0011
707 ANKLE FRACTURE 17 0.0011
708 SPINAL FRACTURE 22 0.0011
709 RENAL IMPAIRMENT 92 0.0011
710 PAIN IN JAW 31 0.0011
711 BRONCHITIS 81 0.0011
712 MANIA 18 0.0011
713 DRUG INEFFECTIVE 1440 0.0011
714 KNEE ARTHROPLASTY 23 0.0011
715 FULL BLOOD COUNT DECREASED 22 0.0011
716 SHOCK 25 0.0011
717 PAIN IN EXTREMITY 320 0.0011
718 DEPRESSION 247 0.0011
719 HAEMATOMA 28 0.0011
720 FATIGUE 841 0.0011
721 ORAL HERPES 21 0.0011
722 ADRENAL INSUFFICIENCY 13 0.0011
723 RASH PAPULAR 24 0.0011
724 CANDIDA INFECTION 18 0.0011
725 THIRST 19 0.0011
726 DISTURBANCE IN ATTENTION 57 0.0011
727 RENAL DISORDER 49 0.0011
728 EXTRAPYRAMIDAL DISORDER 26 0.0010
729 INSURANCE ISSUE 16 0.0010
730 SKIN DISCOLOURATION 48 0.0010
731 MUSCLE SPASMS 191 0.0010
732 DRUG DEPENDENCE 167 0.0010
733 DIARRHOEA 669 0.0010
734 TOOTH DISORDER 23 0.0010
735 TENDONITIS 16 0.0010
736 POST PROCEDURAL HAEMORRHAGE 12 0.0010
737 VENTRICULAR TACHYCARDIA 17 0.0010
738 EYE PAIN 58 0.0010
739 PERIPHERAL SWELLING 157 0.0010
740 CENTRAL NERVOUS SYSTEM LESION 14 0.0010
741 LIVER INJURY 25 0.0010
742 GAIT INABILITY 34 0.0010
743 HEAD DISCOMFORT 18 0.0010
744 BLOOD IRON DECREASED 12 0.0010
745 ATAXIA 12 0.0010
746 POLYNEUROPATHY 12 0.0010
747 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
748 ARRHYTHMIA 47 0.0010
749 INSOMNIA 264 0.0010
750 MEDICATION ERROR 55 0.0010
751 HEART RATE INCREASED 98 0.0010
752 HOSPITALISATION 151 0.0010
753 CEREBRAL INFARCTION 24 0.0010
754 BRONCHOSPASM 14 0.0010
755 MUSCULOSKELETAL PAIN 51 0.0010
756 OROPHARYNGEAL PAIN 90 0.0010
757 MALIGNANT MELANOMA 13 0.0010
758 CONJUNCTIVITIS 18 0.0010
759 DEATH 833 0.0010
760 MOVEMENT DISORDER 31 0.0010
761 CONVULSION 55 0.0010
762 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
763 BLOOD PRESSURE FLUCTUATION 23 0.0010
764 DRUG TOXICITY 13 0.0010
765 SCIATICA 15 0.0009
766 LEUKOPENIA 47 0.0009
767 HEPATIC FUNCTION ABNORMAL 35 0.0009
768 SWELLING FACE 61 0.0009
769 GLAUCOMA 18 0.0009
770 DISCOMFORT 57 0.0009
771 INFUSION SITE PAIN 12 0.0009
772 DIZZINESS 463 0.0009
773 DYSTONIA 18 0.0009
774 INFECTION 134 0.0009
775 PALLOR 25 0.0009
776 ABDOMINAL DISCOMFORT 154 0.0009
777 DISEASE PROGRESSION 108 0.0009
778 MOOD SWINGS 29 0.0009
779 LOCALISED INFECTION 22 0.0009
780 HYPOAESTHESIA 136 0.0009
781 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
782 FIBROMYALGIA 22 0.0009
783 BONE PAIN 53 0.0009
784 HEPATIC CIRRHOSIS 17 0.0009
785 SKIN DISORDER 30 0.0009
786 MYELODYSPLASTIC SYNDROME 13 0.0009
787 PALPITATIONS 105 0.0009
788 MENTAL DISORDER 39 0.0009
789 INCREASED APPETITE 17 0.0009
790 FACE OEDEMA 15 0.0009
791 PRODUCT USE ISSUE 166 0.0009
792 INJURY 62 0.0009
793 HALLUCINATION, AUDITORY 14 0.0009
794 MEMORY IMPAIRMENT 121 0.0009
795 AGGRESSION 44 0.0009
796 ACUTE HEPATIC FAILURE 12 0.0009
797 SKIN EXFOLIATION 74 0.0009
798 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 158 0.0009
799 DIVERTICULITIS 24 0.0009
800 ILLNESS 89 0.0009
801 INTENTIONAL DRUG MISUSE 18 0.0009
802 HYPOACUSIS 37 0.0009
803 THINKING ABNORMAL 16 0.0009
804 ANGER 29 0.0009
805 IMPAIRED HEALING 28 0.0009
806 ABASIA 21 0.0008
807 GLOSSODYNIA 19 0.0008
808 PHARYNGEAL OEDEMA 13 0.0008
809 GASTRIC DISORDER 29 0.0008
810 BLOOD PRESSURE INCREASED 129 0.0008
811 PRODUCT DOSE OMISSION ISSUE 248 0.0008
812 CEREBROVASCULAR ACCIDENT 142 0.0008
813 MIGRAINE 80 0.0008
814 TASTE DISORDER 17 0.0008
815 RASH ERYTHEMATOUS 40 0.0008
816 CHOLESTASIS 16 0.0008
817 PARAESTHESIA 131 0.0008
818 DIABETIC KETOACIDOSIS 20 0.0008
819 HYPERTHYROIDISM 12 0.0008
820 ERUCTATION 16 0.0008
821 CONTRAINDICATED PRODUCT ADMINISTERED 25 0.0008
822 SUICIDE ATTEMPT 50 0.0008
823 TREATMENT NONCOMPLIANCE 45 0.0008
824 INFLAMMATION 42 0.0008
825 PANCREATITIS 43 0.0008
826 MUSCULOSKELETAL DISCOMFORT 14 0.0008
827 VIRAL INFECTION 27 0.0008
828 SINUS DISORDER 16 0.0008
829 TINNITUS 37 0.0008
830 COLON CANCER 12 0.0008
831 RHINORRHOEA 52 0.0008
832 DEAFNESS 21 0.0008
833 HYPERSOMNIA 23 0.0008
834 PRESCRIBED UNDERDOSE 16 0.0008
835 EMOTIONAL DISTRESS 97 0.0008
836 NERVOUS SYSTEM DISORDER 25 0.0008
837 NASAL CONGESTION 47 0.0008
838 ABNORMAL DREAMS 22 0.0008
839 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
840 BLOOD GLUCOSE DECREASED 38 0.0008
841 MULTIPLE FRACTURES 13 0.0008
842 SKIN CANCER 17 0.0008
843 MUSCULOSKELETAL DISORDER 15 0.0008
844 DRY EYE 39 0.0008
845 PRODUCT PRESCRIBING ISSUE 17 0.0008
846 RASH GENERALISED 20 0.0008
847 INFLUENZA 86 0.0008
848 ANGIOEDEMA 34 0.0008
849 BRAIN FOG 12 0.0008
850 VISION BLURRED 105 0.0008
851 MYALGIA 130 0.0008
852 DERMATITIS 16 0.0008
853 RASH PRURITIC 41 0.0008
854 THERAPY NON-RESPONDER 34 0.0008
855 WEIGHT INCREASED 169 0.0008
856 GLYCOSYLATED HAEMOGLOBIN INCREASED 19 0.0008
857 NIGHTMARE 26 0.0008
858 OVERDOSE 162 0.0008
859 CARDIAC DISORDER 70 0.0007
860 RASH MACULAR 26 0.0007
861 CHEST DISCOMFORT 76 0.0007
862 CATARACT 44 0.0007
863 RESPIRATORY DISORDER 22 0.0007
864 MULTIPLE SCLEROSIS RELAPSE 50 0.0007
865 LACRIMATION INCREASED 22 0.0007
866 ARTHRITIS 57 0.0007
867 MYOCARDIAL INFARCTION 126 0.0007
868 EPILEPSY 22 0.0007
869 RASH MACULO-PAPULAR 16 0.0007
870 NEOPLASM PROGRESSION 25 0.0007
871 DEPRESSED MOOD 38 0.0007
872 SKIN FISSURES 14 0.0007
873 EAR INFECTION 19 0.0007
874 BURNING SENSATION 50 0.0007
875 SINUSITIS 73 0.0007
876 MULTIPLE SCLEROSIS 34 0.0007
877 LIMB DISCOMFORT 22 0.0007
878 RETCHING 15 0.0007
879 THROAT TIGHTNESS 19 0.0007
880 HERPES ZOSTER 40 0.0007
881 COMA 33 0.0007
882 UNEVALUABLE EVENT 52 0.0007
883 THERAPY INTERRUPTED 49 0.0007
884 INTENTIONAL PRODUCT USE ISSUE 60 0.0007
885 EYE PRURITUS 23 0.0007
886 PROTEINURIA 13 0.0007
887 THERAPY CESSATION 35 0.0007
888 ARTHRALGIA 283 0.0007
889 SUICIDAL IDEATION 62 0.0007
890 ABDOMINAL PAIN LOWER 17 0.0007
891 FEELING HOT 41 0.0007
892 INTENTIONAL DOSE OMISSION 19 0.0007
893 KIDNEY INFECTION 13 0.0007
894 ERECTILE DYSFUNCTION 17 0.0007
895 DRUG RESISTANCE 17 0.0007
896 PRURITUS 254 0.0007
897 IMPAIRED WORK ABILITY 14 0.0007
898 BLOOD PRESSURE ABNORMAL 13 0.0007
899 GYNAECOMASTIA 20 0.0006
900 PRODUCT ADMINISTRATION ERROR 13 0.0006
901 DRUG-INDUCED LIVER INJURY 20 0.0006
902 RASH 275 0.0006
903 FUNGAL INFECTION 21 0.0006
904 ACCIDENTAL OVERDOSE 23 0.0006
905 HEPATITIS 16 0.0006
906 DYSGEUSIA 46 0.0006
907 EMOTIONAL DISORDER 19 0.0006
908 LABORATORY TEST ABNORMAL 18 0.0006
909 DISABILITY 12 0.0006
910 INCORRECT PRODUCT ADMINISTRATION DURATION 13 0.0006
911 HOT FLUSH 45 0.0006
912 ANAPHYLACTIC SHOCK 15 0.0006
913 VISUAL IMPAIRMENT 72 0.0006
914 JOINT SWELLING 70 0.0006
915 THROAT IRRITATION 26 0.0006
916 ADVERSE DRUG REACTION 52 0.0006
917 PANIC ATTACK 21 0.0006
918 HAEMORRHAGE 60 0.0006
919 IRRITABILITY 34 0.0006
920 EYE SWELLING 21 0.0006
921 FEAR 15 0.0006
922 DEVICE DISLOCATION 24 0.0006
923 OSTEONECROSIS 18 0.0005
924 WOUND 15 0.0005
925 BLOOD GLUCOSE INCREASED 100 0.0005
926 SURGERY 31 0.0005
927 NEOPLASM MALIGNANT 35 0.0005
928 CRYING 19 0.0005
929 JAUNDICE 14 0.0005
930 VISUAL ACUITY REDUCED 17 0.0005
931 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
932 URTICARIA 84 0.0005
933 INCORRECT DRUG ADMINISTRATION DURATION 14 0.0005
934 THERAPEUTIC PRODUCT EFFECT DECREASED 22 0.0005
935 THERAPEUTIC RESPONSE UNEXPECTED 22 0.0005
936 HYPERSENSITIVITY 91 0.0005
937 ANAPHYLACTIC REACTION 27 0.0005
938 FEELING ABNORMAL 117 0.0005
939 INFLUENZA LIKE ILLNESS 40 0.0005
940 ARTHROPATHY 27 0.0005
941 PAIN OF SKIN 13 0.0005
942 DRY SKIN 64 0.0005
943 NERVOUSNESS 25 0.0005
944 INTENTIONAL OVERDOSE 30 0.0005
945 PHARMACEUTICAL PRODUCT COMPLAINT 12 0.0005
946 ROAD TRAFFIC ACCIDENT 19 0.0005
947 NASOPHARYNGITIS 83 0.0004
948 PANCREATIC CARCINOMA 13 0.0004
949 MOOD ALTERED 12 0.0004
950 ILL-DEFINED DISORDER 26 0.0004
951 PRODUCT DOSE OMISSION 27 0.0004
952 FLUSHING 41 0.0004
953 INCORRECT DOSE ADMINISTERED 92 0.0004
954 DRUG WITHDRAWAL SYNDROME 35 0.0004
955 DRUG ADMINISTRATION ERROR 12 0.0004
956 UNDERDOSE 28 0.0004
957 EYE IRRITATION 22 0.0004
958 OCULAR HYPERAEMIA 18 0.0004
959 DEVICE ISSUE 34 0.0004
960 ALOPECIA 74 0.0004
961 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 26 0.0004
962 ECZEMA 19 0.0004
963 INTERSTITIAL LUNG DISEASE 17 0.0004
964 THERAPEUTIC RESPONSE DECREASED 21 0.0003
965 EXTRA DOSE ADMINISTERED 14 0.0003
966 BLINDNESS 14 0.0003
967 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
968 TREATMENT FAILURE 27 0.0003
969 INJECTION SITE MASS 12 0.0003
970 ADVERSE EVENT 29 0.0003
971 NO ADVERSE EVENT 56 0.0003
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 62 0.0003
973 COMPLETED SUICIDE 25 0.0003
974 RHEUMATOID ARTHRITIS 34 0.0003
975 DRUG EFFECT DECREASED 14 0.0003
976 DRUG DOSE OMISSION 42 0.0003
977 ACNE 19 0.0003
978 INJECTION SITE REACTION 17 0.0002
979 PRODUCT SUBSTITUTION ISSUE 14 0.0002
980 PROSTATE CANCER 19 0.0002
981 PRODUCT QUALITY ISSUE 32 0.0002
982 INJECTION SITE BRUISING 18 0.0002
983 INJECTION SITE PRURITUS 15 0.0002
984 BREAST CANCER 19 0.0002
985 MATERNAL EXPOSURE DURING PREGNANCY 18 0.0002
986 INJECTION SITE PAIN 54 0.0002
987 DEVICE MALFUNCTION 12 0.0002
988 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
989 INJECTION SITE SWELLING 12 0.0002
990 INJECTION SITE ERYTHEMA 19 0.0002
991 PSORIASIS 19 0.0001